1-2 of 2
Caterina Lamanna
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

Edoardo Mannucci, MD, Matteo Monami, MD, PHD, Daniela Balzi, MD, Barbara Cresci, MD, Laura Pala, MD, PHD, Cecilia Melani, MD, Caterina Lamanna, MD, Ilaria Bracali, MD, Michela Bigiarini, MD, Alessandro Barchielli, MD, Niccol̀o Marchionni, MD, Carlo Maria Rotella, MD
Journal: Diabetes Care
Diabetes Care 2010;33(9):1997–2003
https://doi.org/10.2337/dc10-0476
Published: 14 June 2010
View article titled, Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Open the PDF for Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients in another window
Includes: Supplementary data
Journal Articles

Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials

Matteo Monami, MD, PHD, Caterina Lamanna, MD, Niccolò Marchionni, MD, Edoardo Mannucci, MD
Journal: Diabetes Care
Diabetes Care 2008;31(7):1455–1460
https://doi.org/10.2337/dc07-2308
Published: 01 July 2008
View article titled, Rosiglitazone and Risk of Cancer: <subtitle>A meta-analysis of randomized clinical trials</subtitle>
Open the PDF for Rosiglitazone and Risk of Cancer: <subtitle>A meta-analysis of randomized clinical trials</subtitle> in another window
Includes: Supplementary data